Genital Herpes - Epidemiology Forecast To 2023
[Report Updated: 31-05-2017]

Published by Delve Insight: 31 May 2017 | 86091

Sorry, this report is no longer available.

We may have other suitable reports available - try Searching for Genital
or contact our sales team for personal assistance: phone +44 (0)7887945155 or email pdb@bioportfolio.co.uk.

Introduction

DelveInsight “Genital Herpes - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Genital Herpes in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Genital Herpes prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Genital Herpes. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

Please note: This report requires 5-7 business days to complete. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope of the Report

• The Report includes the prevalent population and how will it change over the next eight years.

• Prevalent or incident cases segmented by age and sex.

• Coverage of key Genital Herpes subpopulations and its prevalent or incident cases

• The key differences in epidemiology patterns across the seven market segments

Key Coverage and Benefits

• The report will help in developing business strategies by understanding the trends shaping and driving the global Genital Herpes market.

• Identifying prevalent patient populations as well as risk factors in the global Genital Herpes market will help to improve product design, pricing, and launch plans.

• Organize sales and marketing efforts by identifying the best opportunities for Genital Herpes therapeutics in each of the markets covered.

Table of Contents
for Genital Herpes - Epidemiology Forecast To 2023 [Report Updated: 31-05-2017]

List Of Tables
in Genital Herpes - Epidemiology Forecast To 2023 [Report Updated: 31-05-2017]

Table 1: Clinical subtypes of Indication

Table 2: Risk Factors

Table 3: Prevalence cases (%) Region wise

Table 4: Sources used for forecasting the data

Table 5: Genital Herpes Global Epidemiology, (2013-2023)

Table 6: Prevalent Cases of Genital Herpes (Ages =XX Years), US (2013-2023)

Table 7: Prevalent Cases of Genital Herpes By Sex (Males & Females), US (2013-2023)

Table 8: Prevalent Cases By Genital Herpes Sub-population, US (2013-2023)

Table 9: Prevalent Cases of Genital Herpes (Ages =XX Years), United Kingdom (2013-2023)

Table 10: Prevalent Cases of Genital Herpes By Sex (Males & Females), United Kingdom (2013-2023)

Table 11: Prevalent Cases By Genital Herpes Sub-population, United Kingdom (2013-2023)

Table 12: Prevalent Cases of Genital Herpes (Ages =XX Years), Germany (2013-2023)

Table 13: Prevalent Cases of Genital Herpes By Sex (Males & Females), Germany (2013-2023)

Table 14: Prevalent Cases By Genital Herpes Sub-population, Germany (2013-2023)

Table 15: Prevalent Cases of Genital Herpes (Ages =XX Years), France (2013-2023)

Table 16: Prevalent Cases of Genital Herpes By Sex (Males & Females), France (2013-2023)

Table 17: Prevalent Cases By Genital Herpes Sub-population, France (2013-2023)

Table 18: Prevalent Cases of Genital Herpes (Ages =XX Years), Italy (2013-2023)

Table 19: Prevalent Cases of Genital Herpes By Sex (Males & Females), Italy (2013-2023)

Table 20: Prevalent Cases By Genital Herpes Sub-population, Italy (2013-2023)

Table 21: Prevalent Cases of Genital Herpes (Ages =XX Years), Spain (2013-2023)

Table 22: Prevalent Cases of Genital Herpes By Sex (Males & Females), Spain (2013-2023)

Table 23: Prevalent Cases By Genital Herpes Sub-population, Spain (2013-2023)

Table 24: Prevalent Cases of Genital Herpes (Ages =XX Years), Japan (2013-2023)

Table 25: Prevalent Cases of Genital Herpes By Sex (Males & Females), Japan (2013-2023)

Table 26: Prevalent Cases By Genital Herpes Sub-population, Japan (2013-2023)

List Of Figures, Charts and Diagrams
in Genital Herpes - Epidemiology Forecast To 2023 [Report Updated: 31-05-2017]

Figure 1: Prevalence cases (%) Region wise

Figure 2: Sources used for forecasting the data

Figure 3: Genital Herpes Global Epidemiology, (2013-2023)

Figure 4: Prevalent Cases of Genital Herpes (Ages =XX Years), US (2013-2023)

Figure 5: Prevalent Cases of Genital Herpes By Sex (Males & Females), US (2013-2023)

Figure 6: Prevalent Cases By Genital Herpes Sub-population,US (2013-2023)

Figure 7: Prevalent Cases of Genital Herpes (Ages =XX Years), United Kingdom (2013-2023)

Figure 8: Prevalent Cases of Genital Herpes By Sex (Males & Females), United Kingdom (2013-2023)

Figure 9: Prevalent Cases By Genital Herpes Sub-population,United Kingdom (2013-2023)

Figure 10: Prevalent Cases of Genital Herpes (Ages =XX Years), Germany (2013-2023)

Figure 11: Prevalent Cases of Genital Herpes By Sex (Males & Females), Germany (2013-2023)

Figure 12: Prevalent Cases By Genital Herpes Sub-population,Germany (2013-2023)

Figure 13: Prevalent Cases of Genital Herpes (Ages =XX Years), France (2013-2023)

Figure 14: Prevalent Cases of Genital Herpes By Sex (Males & Females), France (2013-2023)

Figure 15: Prevalent Cases By Genital Herpes Sub-population,France (2013-2023)

Figure 16: Prevalent Cases of Genital Herpes (Ages =XX Years), Italy (2013-2023)

Figure 17: Prevalent Cases of Genital Herpes By Sex (Males & Females), Italy (2013-2023)

Figure 18: Prevalent Cases By Genital Herpes Sub-population,Italy (2013-2023)

Figure 19: Prevalent Cases of Genital Herpes (Ages =XX Years), Spain (2013-2023)

Figure 20: Prevalent Cases of Genital Herpes By Sex (Males & Females), Spain (2013-2023)

Figure 21: Prevalent Cases By Genital Herpes Sub-population,Spain (2013-2023)

Figure 22: Prevalent Cases of Genital Herpes (Ages =XX Years), Japan (2013-2023)

Figure 23: Prevalent Cases of Genital Herpes By Sex (Males & Females), Japan (2013-2023)

Figure 24: Prevalent Cases By Genital Herpes Sub-population,Japan (2013-2023)

Additional Details

Publisher

Delve Insight

Publisher Information

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.



We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

Reference

86091 | DIEPR2017104

Number of Pages

40

Report Format

PDF

Delve Insight Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Genital Herpes-API Insights, 2017
The active pharmaceutical ingredients worldwide market is in continuous development from the recent ...
30 May 2017 by Delve Insight USD $1,250 More Info
Genital Herpes - Market Insights, Epidemiology and Market Forecast-2023
Note*: This report requires 5-7 business days to complete.DelveInsight’s Genital Herpes - Market Ins...
30 May 2017 by Delve Insight USD $4,950 More Info
Genital Herpes-Pipeline Insights, 2017
DelveInsight’s, “ Genital Herpes-Pipeline Insights, 2017”, report provides in depth insights on the ...
30 May 2017 by Delve Insight USD $1,250 More Info
Genital Warts (Condylomata Acuminata)-Pipeline Insights, 2017
DelveInsight’s, “ Genital Warts (Condylomata Acuminata)-Pipeline Insights, 2017”, report provides in...
30 May 2017 by Delve Insight USD $1,250 More Info
Genital Herpes-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
DelveInsight’s Report, “Genital Herpes-Global API Manufacturers, Marketed and Phase III Drugs Landsc...
30 May 2017 by Delve Insight USD $2,000 More Info
Genital Warts (Condylomata Acuminata)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
DelveInsight’s Report, “Genital Warts (Condylomata Acuminata)-Global API Manufacturers, Marketed and...
30 May 2017 by Delve Insight USD $2,000 More Info
Genital Herpes - Pipeline Review, H1 2017
Genital Herpes - Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest Pharmaceutical and He...
22 Mar 2017 by Global Markets Direct USD $2,000 More Info
Genital Warts (Condylomata Acuminata) Global Clinical Trials Review, H1, 2016
Genital Warts (Condylomata Acuminata) Global Clinical Trials Review, H1, 2016SummaryGlobalData's cli...
29 Feb 2016 by Global Data USD $2,500 More Info
Genital Herpes Global Clinical Trials Review, H1, 2016
Genital Herpes Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, “Ge...
29 Feb 2016 by Global Data USD $2,500 More Info
Genital Herpes Treatment Market: By Product type (Acyclovir, Famciclovir, Valacyclovir), By Distribution Channel (Hospital Pharmacies, General Pharmacies, Drug stores) & Geography -Forecast (2016-2021)
General herpes is categorised as a sexually transmitted disease/infection (STI) which is caused by h...
18 Feb 2016 by USD $5,250 More Info

This report is published by Delve Insight

DelveInsight is a leading Business Consulting and Market Research Firm. We combine industry expertise with probing market insights in innovative ways to deliver enduring results to deliver critical information to leading decision makers.

We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. DelveInsight is a knowledge partner for business strategy and market research across the drug value chain.

We Stock...